Search

everythinglearnresearchcommunity

for

Search:↓

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Diode laser treatment is safe and effective for reducing unwanted facial hair in hirsutism.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Acupuncture reduces anxiety and depression in women with PCOS.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Biofibre ® 4.0 hair implants are safe and satisfy most patients with hair loss.

GFC is more effective than PRP for treating hair loss.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Bhringraj capsule and oil with Nasya effectively reduce hair fall and related symptoms.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Tailored nonsurgical cosmetic procedures are crucial for safely treating diverse skin types, especially skin of color.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Off-pump heart surgery reduces complications without affecting survival rates compared to on-pump surgery.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Finasteride helps hair growth but may cause sexual side effects.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.